Informations sur le produit
Taselisib is a small-molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) and PI3K-related protein kinases. Taselisib is being investigated as a potential treatment for multiple myeloma, chronic lymphocytic leukemia, and other cancers. Taselisib is an orally available, potent, selective, and ATP competitive inhibitor of PI3K isoforms p110α and p110β. It has been shown to have antiproliferative effects in preclinical models of multiple myeloma, chronic lymphocytic leukemia, solid tumors, and hematopoietic stem cells. It also has anti-inflammatory properties that may be due to its inhibition of the production of proinflammatory cytokines such as tumor necrosis factor-α (TNFα), interleukin 1β (IL1β), IL6, IL8 and IL10.
Propriétés chimiques
Question d’ordre technique sur : 3D-BGC30530 1-Isopropyl-3-methyl-1H-1,2,4-triazole
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages